PMID: 9647057Jul 1, 1998Paper

The Ross procedure: shorter hospital stay, decreased morbidity, and cost effective

The Annals of Thoracic Surgery
J JaggersR M Ungerleider

Abstract

The Ross procedure has become an accepted and sometimes preferred alternative to mechanical aortic valve replacement. One criticism of the Ross procedure is that it may have a higher operative mortality, morbidity, and cost. Several groups have shown that this operation can be performed safely with less than 3% mortality. The issue of higher cost has not been resolved. In this retrospective study we compared a consecutive group of patients undergoing the Ross procedure with an age- and disease-matched group of patients who underwent mechanical aortic valve replacement. From 1993 to 1996, 22 consecutive adult patients (age range, 20 to 57 years; mean, 38 +/- 14 years) underwent the Ross procedure. Twenty-seven patients (age range, 17 to 57 years; mean, 41 +/- 10 years) underwent mechanical aortic valve replacement between 1991 and 1996. The hospital cost (in 1996 dollars) and postoperative length of stay were calculated for each patient using Transition I, a hospital-wide cost accounting system. There was no hospital mortality in either group. The incidence of significant valve-related complication was 5% (1/22 patients) in the Ross procedure group and 22% (6/27 patients) in the mechanical valve group. There were two late deaths...Continue Reading

References

Oct 1, 1987·The Annals of Thoracic Surgery·L H Edmunds
Jun 1, 1994·The Annals of Thoracic Surgery·R C ElkinsM M Lane
Mar 1, 1994·Journal of Cardiac Surgery·R C ElkinsM M Lane
Jan 6, 1994·The New England Journal of Medicine·R C Elkins
Aug 1, 1996·The Annals of Thoracic Surgery·R C ElkinsC McCue
Jun 1, 1997·Annals of Surgery·R M UngerleiderW J Greeley
Jul 1, 1997·The Annals of Thoracic Surgery·R M UngerleiderW J Greeley

❮ Previous
Next ❯

Citations

Jan 17, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Sherri S BakerJennifer S Li
Mar 21, 2002·Artificial Organs·F D da CostaE Matte
Dec 21, 2006·Intensive Care Medicine·Luc JacquetGebrine El Khoury
Aug 25, 2012·The Heart Surgery Forum·Fotios A MitropoulosConstantine E Anagnostopoulos
Apr 15, 2014·Seminars in Thoracic and Cardiovascular Surgery. Pediatric Cardiac Surgery Annual·Sameh M Said, Harold M Burkhart
Jan 25, 2007·Asian Cardiovascular & Thoracic Annals·Mehrdad SalehiMehdi Sanatkar Far
Sep 24, 2004·Journal of Cardiac Surgery·Manuel ConchaRafael Villalba
Mar 13, 2008·Journal of Cardiovascular Medicine·Shi-Min YuanEhud Raanani
Apr 7, 1999·Current Opinion in Cardiology·J D Oswalt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

The Annals of Thoracic Surgery
G B LucianiA Mazzucco
Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery
V SirvydisV Lebetkevicius
© 2022 Meta ULC. All rights reserved